Showing 1 - 20 results of 21 for search '(( significantly increased decrease ) OR ( ((significant bins) OR (significant non)) decrease ))~', query time: 0.51s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Table 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.docx by Yazhao Mei (13041882)

    Published 2025
    “…</p>Results<p>Pediatric denosumab recipients exhibited significant LS-BMD (+30.3%, P<0.001) and FN-BMD gains (+38.7%, P=0.001) versus baseline, whereas adults showed non-significant increases (LS: +2.6%, P=0.100; FN: +4.4%, P=0.051). …”
  15. 15

    Image 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.tif by Yazhao Mei (13041882)

    Published 2025
    “…</p>Results<p>Pediatric denosumab recipients exhibited significant LS-BMD (+30.3%, P<0.001) and FN-BMD gains (+38.7%, P=0.001) versus baseline, whereas adults showed non-significant increases (LS: +2.6%, P=0.100; FN: +4.4%, P=0.051). …”
  16. 16

    Image 2_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.tif by Yazhao Mei (13041882)

    Published 2025
    “…</p>Results<p>Pediatric denosumab recipients exhibited significant LS-BMD (+30.3%, P<0.001) and FN-BMD gains (+38.7%, P=0.001) versus baseline, whereas adults showed non-significant increases (LS: +2.6%, P=0.100; FN: +4.4%, P=0.051). …”
  17. 17
  18. 18
  19. 19
  20. 20